SCHEMBL2939829

SCHEMBL2939829

CN1CCC(C(=O)c2cnccc2C(N)N2C(=O)N(c3ccc(S(=O)(=O)C(F)(F)F)cc3)C(=O)C2(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 7/20 0.39
NAMPT P43490 4/20 0.31
EPHX2 P34913 1/20 0.31
DPP4 P27487 1/20 0.30
DPP7 Q9UHL4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171681 0.79 IGF1R (0.43) IGF1RNAMPT
SCHEMBL6171670 0.75 IGF1R (0.38) IGF1R
SCHEMBL2939826 0.74 IGF1R (0.53) IGF1REPHX2
SCHEMBL6173623 0.74 IGF1R (0.38) IGF1RNAMPT
SCHEMBL2941440 0.72 IGF1R (0.56) IGF1R
SCHEMBL2938212 0.71 IGF1R (0.40) IGF1R
SCHEMBL2941481 0.70 IGF1R (0.62) IGF1RNAMPT
SCHEMBL2942119 0.70 IGF1R (0.58) IGF1R
SCHEMBL2936682 0.69 IGF1R (0.63) IGF1R
SCHEMBL2940341 0.69 IGF1R (0.40) IGF1RNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed